Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus

Summary

This is a single-arm, multi-site, proof-of-concept study that will evaluate the treatment of 10 participants with cutaneous lupus erythematosus (CLE) with Tofacitinib.

Timeline

Start

2022-09-30

Primary completion

2024-02-15

Completion

2024-02-29

Drugs

Indications